放疗配合泰索帝Weekly方案治疗局部晚期非小细胞肺癌近期疗效观察
出处
《山东医药》
CAS
北大核心
2001年第18期29-30,共2页
Shandong Medical Journal
参考文献6
-
1[1]Tomiak E,Piccart MJ,Kerger J,et a l.Pha se I study of docetaxel administered as a 1-hour intravenous infusion on a Weekl y basis.J Clin Oncol,1994,12:1458~67.
-
2[2]Hai nsworth JD,Greco FA.Ppase I trial of wee kly infusion in patients with advanced r efractory cancer.J Clin Oncol,1998,16:21 64~2168.
-
3[3]Choy H,Ridriguez F,Hilsenbeck S,e t al.Symergisstic effe cts of Taxol?Taxotere on radiation sesit ivity on human tumor cell.Int J Radiat O ncol Biol Phys,1999,24:274~275.
-
4[4]Millwar d MJ,Zalcberg J,Bishop JF,et al.Phase I trial of docetaxel and cisplati in previ ously untreated patients with advanced n on-small-cell lung cancer.J Clin Oncol,1 997,15:750~758.
-
5[5]Koukourakis MI,Bahlitzan akis N,Froudarakis M.Concurrent conventi onally fractionated radiotherapy and wee kly docetaxel in the treatment of stage Ⅲb non-small-cell lung carcinoma.Br J Ca ncer,1999,Aug;80(11):1792~1796.
-
6[6]Koukou rakis MI,Bizakis JG,Skoulakis CE.Combine d irinotecan,docetaxel and conventionall y fractionted radotherapy in locally adv anced head and neck cancer.A phase 1 dos e escalation study.Anticancer Res,1999,1 9(3B):2305~2309.
-
1刘宏,王庆伟,乔乃安,程玉峰,刘惠中.泰索帝Weekly方案配合放疗治疗局部晚期非小细胞肺癌近期疗效评价[J].肿瘤防治研究,2002,29(4):263-263. 被引量:1
-
2李晓军,王岭,凌瑞.乳腺癌新辅助化疗的临床疗效观察[J].现代肿瘤医学,2005,13(5):649-650. 被引量:7
-
3菅逸斐.一例恶性淋巴瘤化疗患者的饮食护理[J].中国疗养医学,2009,18(6):523-524. 被引量:3
-
4邓云.^(131)I治疗对分化型甲状腺癌患者肝肾功能的影响[J].广西医科大学学报,2014,31(6):1007-1008. 被引量:4
-
5吕长兴,刘俊,王家明,王常禄,郭金栋,潘方华,蒋杰.两周期诱导化疗后Ⅲ期非小细胞肺癌同步放化疗的疗效分析[J].中国肺癌杂志,2005,8(1):48-50. 被引量:13
-
6马晓东,张纪,王迎选.立体定向放射外科追加剂量治疗恶性胶质瘤[J].中华神经外科杂志,1997,13(4):243-245. 被引量:2
-
7马群,罗素霞,王建华.放化结合治疗中晚期食管癌疗效观察[J].中国民康医学,2007,19(13):565-565. 被引量:2
-
8赵秀升,陈蓉艳,赵玉霞,孙萍.同期放化疗治疗非小细胞肺癌脑转移疗效评价[J].医药论坛杂志,2007,28(5):79-80. 被引量:3
-
9菲琳.Xeloda与Taxotere联合治疗乳腺癌疗效显著[J].国外医学情报,2002,23(10):42-42. 被引量:1
-
10曲妥珠单抗加多西紫杉醇可改善转移性乳腺癌患者的生存[J].中华医学信息导报,2005,20(15):9-9.